Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.

Rev Esp Cardiol. 2006 Jun;59(6):537-44. Spanish.

2.

Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.

Maron BJ, Spirito P.

J Cardiovasc Electrophysiol. 2008 Oct;19(10):1118-26. doi: 10.1111/j.1540-8167.2008.01147.x. Epub 2008 Mar 31. Review.

PMID:
18384577
3.

[Interventional treatment in hypertrophic cardiomyopathy].

Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S.

Herz. 2005 Mar;30(2):102-10. Review. German.

PMID:
15875098
4.

Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.

Hilleman DE, Bauman AL.

Pharmacotherapy. 2001 May;21(5):556-75. Review.

PMID:
11349745
5.

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.

Schinkel AF, Vriesendorp PA, Sijbrands EJ, Jordaens LJ, ten Cate FJ, Michels M.

Circ Heart Fail. 2012 Sep 1;5(5):552-9. Epub 2012 Jul 20. Review.

6.

Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.

Cotiga D, Ehlert F, Sherrid M.

Anadolu Kardiyol Derg. 2006 Dec;6 Suppl 2:55-60. Review.

8.

Indications for implantable cardioverter defibrillator therapy.

Sorbera CA, Cusack EJ.

Heart Dis. 2002 May-Jun;4(3):166-70. Review.

PMID:
12028602
9.
10.

Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.

Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM Jr.

J Am Coll Cardiol. 2009 Nov 24;54(22):1993-2000. doi: 10.1016/j.jacc.2009.07.039. Review.

11.

Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death.

Akhtar M, Jazayeri M, Sra J, Tchou P, Rovang K, Blanck Z, Dhala A, Deshpande S, Axtell K.

Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 2):511-8. Review.

PMID:
7681950
12.

Sudden death and hypertrophic cardiomyopathy: a review.

Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.

Can J Cardiol. 2005 Apr;21(5):441-8. Review.

PMID:
15861263
14.
15.

[Indications for the implantable cardiac defibrillator].

Ben Ameur Y, Baraket F, Terras M, Longo S, Kraiem S, Hmem M, Slimane ML.

Tunis Med. 2003;81 Suppl 8:601-12. Review. French.

PMID:
14608747
17.

Use of implantable pacemakers and implantable defibrillators in hypertrophic cardiomyopathy.

Freedman RA.

Curr Opin Cardiol. 2001 Jan;16(1):58-65. Review.

PMID:
11124720
18.

Implantable cardioverter-defibrillator follow-up: what everyone needs to know.

Wilbur SL, Marchlinski FE.

Cardiol Rev. 1999 Jul-Aug;7(4):176-90. Review.

PMID:
10423669
19.
20.

Indications for an implantable cardioverter defibrillator (ICD).

Aizawa Y, Chinushi M, Washizuka T.

Intern Med. 2004 May;43(5):360-7. Review.

Supplemental Content

Support Center